Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL

NCT01696435 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT01696435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01696435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
Lead sponsor
Brigham and Women's Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2010
Completion date
March 31, 2025
Enrollment
18,353 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, depressive symptoms, mood